Phosphorylation of h1 Calponin by PKC epsilon may contribute to facilitate the contraction of uterine myometrium in mice during pregnancy and labor
© Li et al.; licensee BioMed Central Ltd. 2012
Received: 12 December 2011
Accepted: 3 April 2012
Published: 2 May 2012
The timely onset of powerful uterine contractions during parturition occurs through thick and thin filament interactions, similar to other smooth muscle tissues. Calponin is one of the thin filament proteins. Phosphorylation of calponin induced by PKC-epsilon can promote the contraction of vascular smooth muscle. While the mechanism by which calponin regulates the contraction of pregnant myometrium has rarely been explored. Here, we explore whether PKC-epsilon/h1 calponin pathway contribute to regulation of myometrial contractility and development of parturition.
We detected the expression of h1 calponin, phosphorylated h1 calponin, PKC-epsilon and phosphorylated PKC-epsilon in the different stages of mice during pregnancy and in labor by the method of western blot and recorded the contraction activity of myometrium strips at the 19th day during pregnancy with different treatments by the organ bath experiments.
The level of the four proteins including h1 calponin, phosphorylated h1 calponin, PKC-epsilon and phosphorylated PKC-epsilon was significantly increased in pregnant mice myometrium as compared with that in nonpregnant mice. The ratios of phosphorylated h1 calponin/h1 calponin and phosphorylated PKC-epsilon/PKC-epsilon were reached the peak after the onset of labor in myometrium in the mice. After the treatment of more than 10(9-) mol/L Psi-RACK (PKC-epsilon activator), the contractility of myometrium strips from mice was reinforced and the level of phosphorylated h1 calponin increased at the same time which could be interrupted by the specific inhibitor of PKC-epsilon. Meanwhile, the change of the ratio of phosphorylated h1 calponin/h1 calponin was consistent with that of contraction force of mice myometrium strips.
These data suggest that in mice myometrium, phosphorylation of h1 calponin induced by the PKC-epsilon might facilitate the contraction of uterine in labor and regulate pregnant myometrial contractility.
Keywordsh1 Calponin PKC-epsilon Phosphorylation Mice Labor Pregnancy
Labor may occur due to a loss of myometrial quiescence or an active increase in uterine contractility, or a combination of both. Several contractile-associated proteins have been proposed to contribute to reversal of quiescence and promote contraction of the uterus during labor [1, 2]. Calponin is one of the thin filament proteins and a critical component of smooth muscle contractile machinery , while the mechanism by which calponin regulates the contraction of pregnant myometrium has rarely been explored. Calponin (CaP) was first isolated in smooth muscle over 20 years ago as a potential thin filament regulatory protein . So far, Calponin is now known as a family of homologous actin filament-associated proteins expressed in both smooth muscle and non-muscle cells. Three isoforms of calponin have been found in the vertebrates as the products of three homologous genes: a basic calponin (smooth muscle-specific basic CaP, h1-calponin, h1 CaP) , a neutral calponin (h2-calponin)  and an acidic Calponin (h3 calponin) .
A series of animal experiments have been conducted about the role of calponin in smooth muscle contraction, the findings show the h1 calponin is specific to differentiated smooth muscle cells and up-regulated during post-natal development , which consistent with a role in contractile function. Calponin inhibits the contraction of smooth muscle through its interacting with actin and Calmodulin and inhibiting action-activated myosin ATPase activity without affecting myosin light chain (LC20) phosphorylation , but the phosphorylation of calponin induced by PKC, in particular PKC-ε displays a dramatic reduction in affinity for actin and is unable to inhibit myosin ATPase activity which promotes the contraction of smooth muscle. Phosphorylation of calponin by PKC-ε results in contraction of porcine coronary artery  whereas unphosphorylated calponin relaxes single permeabilized vascular smooth cells pre-contracted with phenylephrine and PKC-ε . Previously, Winder  found Calponin was a substrate for PKC in 1990, followed by the discovery by Horowitz  that calponin is a substrate for PKC-ε. Whereafter, Menice  found that PKC-ε and h1 calponin co-immunoprecipitate and co-translocate to the vicinity of the plasmalemma in ferret vascular smooth muscle and that PKC-ε directly binds to h1 calponin in vitro . The subcellular localization of calponin is also affected by PKC-dependent phosphorylation. Moreover, dephosphorylation of calponin by a type 2A protein phosphatase restores actin binding and inhibition of myosin ATPase . In general, it has been postulated that agonist-induced, Ca2 + -independent contraction of smooth muscle is mediated by PKC-ε through its ability to phosphorylate calponin.
Although the function of h1 calponin in smooth muscle contraction has been extensively investigated, the physiological function of calponin in uterine myometrium is still inconclusive because relatively few studies have been performed in pregnant myometrium regarding the possible function of h1 calponin and PKC-ε. However, the information established from vascular smooth muscle studies laid a foundation for investigations on the function of h1 calponin in uterine myometrium. An increased protein level of h1 calponin in term pregnant human myometrium has been reported , but the mechanism by which h1 calponin regulates myometrium contraction has not been explored. Then, a new idea was presented whether the contraction of gestational myometrial was regulated by the PKC-ε/ h1 calponin signaling. Whether the inhibition of h1 calponin on actin may be reversed by PKC-ε-dependent phosphorylation in a gestation-related manner has not been explored. The purpose of the present study was to determine if the activation of PKC-ε and phosphorylation of h1 calponin might correlate with the onset of labor and whether phosphorylation of h1 calponin induced by PKC-ε regulates pregnant myometrial contractility in mice.
Animals and tissue handling
All procedures were approved by our institutional animal care and use committee. 8-week-old female BALB/C mice were randomly divided into seven groups (10 mice per group): nonpregnant(NP), pregnant D7(the 7th day during pregnancy), pregnant D12(the 12th day during pregnancy), pregnant D17(the 17th day during pregnancy), pregnant D18(the 18th day during pregnancy), pregnant D19(the 19th day during pregnancy), in labor (IL, after the first pup was delivered). Mice were killed by cervical dislocation. Uterine horns were excised and opened up along the mid-line. In pregnant mice, the placentae and fetuses were removed and pups decapitated. Longitudinal strips of myometrium were isolated from the tissue and freed of any endometrium, under a dissecting microscope, and cleaned of any blood by rinsing in Krebs solution (154 mM NaCl, 5.4 mM KCl, 1.2 mM MgSO4, 1.6 mM CaCl2, 5.5 mM glucose, and oxygenated with 95% O2-5% CO2, producing a pH of 7.4). The strips were snap frozen in liquid N2 until use, or prepared immediately for contractile studies.
Western blot analysis
Muscles were stored in liquid N2 until processed as previously described for protein extraction for Western blotting . The concentration of extracted proteins was determined by the Bradford Protein Assay kit (Santa Cruz, USA) according to the manufacturer’s instructions. Samples were subjected to electrophoresis on 10% SDS polyacrylamide gels. Gels were sealed with a blotting membrane. Membranes were placed into blocking buffer containing 5% non-fat milk and incubated for 2 hours at room temperature on a rocking platform. Primary antibody was added to each lane and incubated for 2 h, followed by three 10 min washes with TBST. Secondary antibody (1:10,000, Santa Cruz, USA) was then added to each lane and incubated for 1h, and the blot was subjected to three 10 min washes in TBST. Immunoreactivity was visualized by enhanced chemiluminescence (ECL Pierce Company, USA), images were captured on X-ray film (Kodak, American), and protein quantification was determined by using Gel Pro Analyzer 4 image analysis software (Media Cybernetics, USA). The h1 calponin antibody (1:3000, Millipore, USA) detected total h1 calponin protein levels. The phospho-h1 calponin antibody (1:1000, Santa Cruz, USA) used in this study was specific for the PKC (Protein kinase C) phosphorylation site at Ser175. The PKC-ε antibody (1:1000, Millipore, USA) was used to detect total PKC-ε protein levels. The phospho- PKC-ε antibody (1:1000, Santa Cruz, USA) used in this study detected phosphorylated PKC-ε which was catalytically activated by phosphorylation at Ser729.
Strips of myometrium (7 ~ 8 mm length × 2 ~ 3mm wide) were dissected from mice uterine at the time of Day 19 in pregnancy, tied at each end with silk thread and mounted vertically in 30-ml tissue baths. One tissue end was tied to a fixed hook, the other to an isometric tension transducer (Chengdu Instruments, China) and equilibrated in Krebs solution (154 mM NaCl, 5.4 mM KCl, 1.2 mM MgSO4, 1.6 mM CaCl2, 5.5 mM glucose, and oxygenated with 95% O2-5% CO2, producing a pH of 7.4). Experiments were performed at 37°C as previously described . Preparations were allowed to equilibrate for 1 h before initiation of experiments. All myometrial strips were stretched to the optimal length, defined as the length corresponding to maximal force development with regard to spontaneous contraction . The bath buffer solution was changed every 15 minutes during equilibration. The contractile activity was digitalized with BL-420E + biological and functional experimental system (Chengdu Technology & Market Co, LTD, China). To investigate the role of PKC-ε/ h1 calponin pathway to contractile activation, myometrial strips isolated from mice at the 19th day during pregnancy were stimulated with the PKC-ε specific activator (Psi-RACK, Anaspec, American), with the concentration ranging from 10-12 mol/L to 10-6 mol/L. The control group underwent a Psi-RACK concentration of 0 mol/L. To further investigate whether PKC-ε was involved in the phosphorylation of h1 calponin, 10-9 mol/L epsilon-V1-2 (PKC-ε specific inhibitor, Anaspec, American) was administered to the tissue baths after adding 10-9 mol/L Psi-RACK(PKC-ε activator) and not adding Psi-RACK groups. At the end of experiments, muscle strips were snapping frozen in liquid N2 for Western Blot Analysis.
Data were presented as mean ± standard deviation (SD). Statistical significance was determined by one-way ANOVA using the SPSS 13.0 statistics package. Statistical significance was set at P < 0.05.
The expression and phosphorylation of h1 calponin were increased during pregnancy and labor
The expression and phosphorylation of PKC-ε were increased during pregnancy and labor
The effect of PKC-ε activator and inhibitor on the expression and phosphorylation of h1 calponin in the mice myometrium strips
As in all muscle tissue, the predominant proteins expressed in uterine smooth muscle are myosin and actin. In uterine smooth muscle, there is ~6-fold more actin than myosin . Thin filaments (6-8 nm diameters) are polymers of globular monomeric actin. Thick filaments (15-18 nm diameters) are made up of myosin. In general, the actin and myosin filaments run in parallel and in the longitudinal dimension of the cell. All contractility is initiated by changes in the activity of, or interactions of, actin and myosin. In recent years, multitudes of signaling pathways have been suggested to regulate smooth muscle contractility; however, mechanisms that regulate the availability of actin to interact with myosin via the action of inhibitory actin binding proteins such as caldesmon (CaD) and possibly calponin (CaP) are strongly implicated in preterm labor. During pregnancy, myometrial smooth muscle undergo profound and large changes, including disruption of the myofilaments or cytoskeleton. It is necessary to recover greater amounts of thin filament-associated proteins from nonpregnant tissues. Calponin may be expressed at levels reaching stoichiometric equivalence with actin, and has been proposed to be a load-bearing protein. H1 calponin is one of the thin filament proteins, which plays a role in the formation of cytoskeleton .
We have observed the protein expression of h1 calponin in the uterine of mice, which was detected with the method of Western Blot during different trimester of pregnancy. Here we demonstrated that h1 calponin protein level significantly increased in mice myometrium in late pregnancy and during labor compared with nonpregnant controls. The gain of h1 calponin may contribute to recover the cytoskeleton in the pregnant myometrium. The difference of the protein expression of h1 calponin not only demonstrated that the expression of h1 calponin was associated with the physiological state of mice but also suggested that the alternation of the h1 calponin during pregnancy laid the groundwork for regulating the contraction of mice uterine.
Reversible phosphorylation of proteins is an important regulatory mechanism that occurs in both prokaryotic and eukaryotic organisms. Many enzymes and receptors are switched "on" or "off" by phosphorylation and dephosphorylation. Protein phosphorylation is an omnipresent and important dynamic phenomenon in living systems that affects protein structure, protein-protein interactions and catalytic activity during physiological processes. The phospho-h1 calponin antibody used in this study is specific for h1 calponin phosphorylated at a PKC phosphorylation site, Ser175. PKC is a family including conventional isoforms(α, β, and γ), novel isoforms (δ, ε, η, and θ), atypical isoforms (i/λ and ξ) and PKD/μ . Some studies indicate h1 calponin is the possible target of PKC-ε, and PKC-ε can interact with h1 calponin through the C-terminal repeats . The PKC-ε is widely expressed throughout the body and has important roles in the function of the nervous , cardiac and immune  systems. It is an attractive drug target for the treatment of several conditions such as inflammation , ischemia , addiction , pain , anxiety , and cancer . Therefore, there is interest in discovering additional drug targets through identification of PKC-ε substrates and the signal pathways in which they participate.
In our experiments, it was been found that PKC-ε was activated with the use of its specific antibody in the western blot in labor, at the same time an increase in phosphorylation of h1 calponin at the Ser175 site was observed. The outcomes suggested that h1 calponin and its phosphorylation were helpful to or associated with labor. Meanwhile, we have designed the following organ bath experiments with the purpose of promoting the contraction of uterine myometrium at the time of Day 19 in pregnancy: 1. Muscle tension was recorded with isometric force transducers connected to a computer-controlled Gemini recorder (Chengdu Instruments, China) after the application of different dose of the activator of PKC-ε and of inhibitor of PKC-ε. 2. The levels of h1 calponin and phospho-h1 calponin were detected with the method of western blot spontaneously. The experimental results showed that the mean amplitude of the myometrium contractions and the ratio of phospho-h1 calponin/h1 calponin representing the degree of phosphorylation of the h1 calponin in the myometrial strips of mice were increased by exposing myometrial strips to Psi-RACK (the PKC-ε specific activator) more than 10-9 mol/L Psi-RACK, a PKC-ε specific activator, which can activate the PKC-ε to phosphorylated h1 calponin. Still, a positive correlation was found between the amplitude of the myometrium strips and the degree of h1 calponin phosphorylation. All these findings gave us suggestion that contractions of myometrium strips in labor mice were promoted by phospho-h1 calponin. Furthermore, another step was established to verify the effect of PKC-ε on the h1 Calponin: contractions of day 19 pregnant mice myometrium were recorded after adding some inhibitor of PKC-ε(epsilon-V1-2) followed by adding the PKC-ε activator(10-9 mol/L Psi-RACK) into the medium of organ bath. We found that epsilon-V1-2 could decrease the level of phospho-h1 calponin on stips activated by Psi-RACK, but had no significant effect on the contraction of non-activated strips. Epsilon-V1-2 is a 14- to 21-peptide sequence derived from the first variable region V1 of the regulatory domain of PKC-ε [31, 32]. Its inhibitory activity is based on PKC-ε translocation and PKC-ε phosphorylation. We conjectured that PKC-ε translocation and phosphorylation were not significantly happened in the strips without adding Psi-RACK. So epsilon-V1-2 had no significantly effect on the contraction of non-activated strips. The result of this step could imply that the phosphorylation of h1 Calponin was caused by the PKC-ε.
In vascular smooth muscle, through a PKC-ε-mediated h1 calponin phosphorylation, h1 calponin becomes disassociated from acto-myosin, allowing for cross-bridging, thus initiating smooth muscle contraction . All findings in our studies strongly implicated PKC-ε-dependent h1 calponin phosphorylation have been linked to uterine smooth muscle contraction. Thus we postulate that PKC-ε-dependent h1 calponin phosphorylation may reverse the inhibition of actomyosin interactions by h1 calponin and may contribute to an increased uterine contractility during labor.
In conclusion, we demonstrated that the PKC-ε activation, phosphorylation of h1 calponin at a PKC site reached the peak in myometrium in the mice in labor. Under the stimulation of the PKC-ε specific activator, the contractility of myometrium strips from pregnant mice was reinforced and the level of phosphorylated h1 calponin increased at the same time, which could be interrupted by the specific inhibitor of PKC-ε. These results constitute evidence for a role of the PKC-ε/h1 calponin pathway in the regulation of myometrial contractility and development of parturition.
This work was supported by a Grant from the Sci-Tech Project Foundation of Hunan Province, China (Grant Number: 2010SK3126) and a PhD Innovation Grant from Hunan Province, China (Grant Number: CX2010B059).
- Riley M, Wu X, Baker PN, Taggart MJ: Gestational-dependent changes in the expression of signal transduction and contractile filament-associated proteins in mouse myometrium. J Soc Gynecol Investig. 2005, 12: e33-e43. 10.1016/j.jsgi.2005.04.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Li Y, Je HD, Malek S, Morgan KG: ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor. Am J Physiol Regul Integr Comp Physiol. 2003, 284: R192-R199.View ArticlePubMedGoogle Scholar
- Kim H, Appel S, Vetterkind S, Gangopadhyay S, Morgan K: Smooth muscle signalling pathways in health and disease. J Cell Mol Med. 2008, 12: 2165-2180. 10.1111/j.1582-4934.2008.00552.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Winder SJ, Walsh MP: Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem. 1990, 265: 10148-10155.PubMedGoogle Scholar
- Takahashi K, Abe M, Hiwada K, Kokubu T: A novel troponin T-like protein (calponin) in vascular smooth muscle: interaction with tropomyosin paracrystals. J Hypertens Suppl. 1988, 6: S40-S43.View ArticlePubMedGoogle Scholar
- Strasser P, Gimona M, Moessler H, Herzog M, Small JV: Mammalian calponin, Identification and expression of genetic variants. FEBS Lett. 1993, 330: 13-18. 10.1016/0014-5793(93)80909-E.View ArticlePubMedGoogle Scholar
- Applegate D, Feng W, Green RS, Taubman MB: Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. J Biol Chem. 1994, 269: 10683-10690.PubMedGoogle Scholar
- Hossain MM, Hwang DY, Huang QQ, Sasaki Y, Jin JP: Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am J Physiol Cell Physiol. 2003, 284: C156-C167.View ArticlePubMedGoogle Scholar
- Makuch R, Birukov K, Shirinsky V, Dabrowska R: Functional interrelationship between calponin and caldesmon. Biochem J. 1991, 280 (Pt 1): 33-38.PubMed CentralView ArticlePubMedGoogle Scholar
- Mino T, Yuasa U, Naka M, Tanaka T: Phosphorylation of calponin mediated by protein kinase C in association with contraction in porcine coronary artery. Biochem Biophys Res Commun. 1995, 208: 397-404. 10.1006/bbrc.1995.1351.View ArticlePubMedGoogle Scholar
- Horowitz A, Clement-Chomienne O, Walsh MP, Morgan KG: Epsilon-isoenzyme of protein kinase C induces a Ca(2+)-independent contraction in vascular smooth muscle. Am J Physiol. 1996, 271: C589-C594.PubMedGoogle Scholar
- Menice CB, Hulvershorn J, Adam LP, Wang CA, Morgan KG: Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem. 1997, 272: 25157-25161. 10.1074/jbc.272.40.25157.View ArticlePubMedGoogle Scholar
- Leinweber B, Parissenti AM, Gallant C, Gangopadhyay SS, Kirwan-Rhude A, Leavis PC, Morgan KG: Regulation of protein kinase C by the cytoskeletal protein calponin. J Biol Chem. 2000, 275: 40329-40336. 10.1074/jbc.M008257200.View ArticlePubMedGoogle Scholar
- Winder SJ, Pato MD, Walsh MP: Purification and characterization of calponin phosphatase from smooth muscle, Effect of dephosphorylation on calponin function. Biochem J. 1992, 286 (Pt 1): 197-203.PubMed CentralView ArticlePubMedGoogle Scholar
- Cornwell TL, Li J, Sellak H, Miller RT, Word RA: Reorganization of myofilament proteins and decreased cGMP-dependent protein kinase in the human uterus during pregnancy. J Clin Endocrinol Metab. 2001, 86: 3981-3988. 10.1210/jc.86.8.3981.View ArticlePubMedGoogle Scholar
- Je HD, Gangopadhyay SS, Ashworth TD, Morgan KG: Calponin is required for agonist-induced signal transduction–evidence from an antisense approach in ferret smooth muscle. J Physiol. 2001, 537: 567-577. 10.1111/j.1469-7793.2001.00567.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Szal SE, Repke JT, Seely EW, Graves SW, Parker CA, Morgan KG: [Ca2+]i signaling in pregnant human myometrium. Am J Physiol. 1994, 267: E77-E87.PubMedGoogle Scholar
- Herlihy JT, Murphy RA: Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res. 1973, 33: 275-283. 10.1161/01.RES.33.3.275.View ArticlePubMedGoogle Scholar
- Brandman R, Disatnik MH, Churchill E, Mochly-Rosen D: Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J Biol Chem. 2007, 282: 4113-4123.View ArticlePubMedGoogle Scholar
- Word RA, Stull JT, Casey ML, Kamm KE: Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women. J Clin Invest. 1993, 92: 29-37. 10.1172/JCI116564.PubMed CentralView ArticlePubMedGoogle Scholar
- Gusev NB: Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation. Biochemistry (Mosc). 2001, 66: 1112-1121. 10.1023/A:1012480829618.View ArticleGoogle Scholar
- Newton AC: Regulation of protein kinase C. Curr Opin Cell Biol. 1997, 9: 161-167. 10.1016/S0955-0674(97)80058-0.View ArticlePubMedGoogle Scholar
- Shirai Y, Adachi N, Saito N: Protein kinase Cepsilon: function in neurons. FEBS J. 2008, 275: 3988-3994. 10.1111/j.1742-4658.2008.06556.x.View ArticlePubMedGoogle Scholar
- Churchill EN, Mochly-Rosen D: The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans. 2007, 35: 1040-1042. 10.1042/BST0351040.View ArticlePubMedGoogle Scholar
- Aksoy E, Goldman M, Willems F: Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol. 2004, 36: 183-188. 10.1016/S1357-2725(03)00210-3.View ArticlePubMedGoogle Scholar
- Budas GR, Mochly-Rosen D: Mitochondrial protein kinase Cepsilon (PKCepsilon): emerging role in cardiac protection from ischaemic damage. Biochem Soc Trans. 2007, 35: 1052-1054. 10.1042/BST0351052.View ArticlePubMedGoogle Scholar
- Newton PM, Messing RO: Intracellular signaling pathways that regulate behavioral responses to ethanol. Pharmacol Ther. 2006, 109: 227-237. 10.1016/j.pharmthera.2005.07.004.View ArticlePubMedGoogle Scholar
- Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, et al: A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron. 1999, 24: 253-260. 10.1016/S0896-6273(00)80837-5.View ArticlePubMedGoogle Scholar
- Lesscher HM, McMahon T, Lasek AW, Chou WH, Connolly J, Kharazia V, Messing RO: Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior. Genes Brain Behav. 2008, 7: 323-333. 10.1111/j.1601-183X.2007.00356.x.View ArticlePubMedGoogle Scholar
- Gorin MA, Pan Q: Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer. 2009, 8: 9-10.1186/1476-4598-8-9.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, et al: Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A. 2001, 98: 11114-11119. 10.1073/pnas.191369098.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen L, Wright LR, Chen CH, Oliver SF, Wender PA, Mochly-Rosen D: Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol. 2001, 8: 1123-1129. 10.1016/S1074-5521(01)00076-X.View ArticlePubMedGoogle Scholar
- Dallas A, Khalil RA: Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of∊-protein kinase C-dependent pathway. Am J Physiol Cell Physiol. 2003, 285: C1454-C1463.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.